Study of Mindfulness-Based Cognitive Therapy (MBCT)

September 19, 2012 updated by: Sean Barnes, Binghamton University

Toward Identifying the Mechanisms of Action in Mindfulness-Based Cognitive Therapy

Research aimed at assessing changes in depressogenic thinking and the ability to disengage from depressogenic thinking following Mindfulness-Based Cognitive Therapy

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of two or more Major Depressive Episodes or history of a Major Depressive Episode lasting at least one year
  • Can speak, read, and understand English

Exclusion Criteria:

  • Meet Criteria for Current Major Depressive Episode or are in partial remission
  • BDI-II score above 19
  • Abuse alcohol or drugs
  • Current Dysthymic Disorder
  • History of: psychosis when not depressed or intoxicated, Mania, Hypomania, Obsessive Compulsive Disorder, Posttraumatic Stress Disorder, Anorexia Nervosa, Bulimia Nervosa

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Mindfulness-Based Cognitive Therapy plus treatment as usual
Behavioral: Mindfulness-Based Cognitive Therapy
Mindfulness-Based Cognitive Therapy for the prevention of depressive relapse/recurrence
NO_INTERVENTION: MBCT Waitlist plus Treatment as Usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Sustained Attention to Response Task
Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment
zero to four weeks pre-treatment and zero to three weeks post-treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
Five Facet Mindfulness Questionnaire
Time Frame: zero to four weeks pre-treatment and zero to three weeks post-treatment
zero to four weeks pre-treatment and zero to three weeks post-treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Binghamton University

Investigators

  • Principal Investigator: Sean M. Barnes, MS, Binghamton University SUNY

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (ACTUAL)

July 1, 2010

Study Completion (ACTUAL)

July 1, 2010

Study Registration Dates

First Submitted

July 13, 2009

First Submitted That Met QC Criteria

July 20, 2009

First Posted (ESTIMATE)

July 21, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

September 21, 2012

Last Update Submitted That Met QC Criteria

September 19, 2012

Last Verified

September 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MLI-FJVRF-08-SMB

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on Mindfulness-Based Cognitive Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe